Unique considerations in the evaluation of antibacterials in clinical trials for pediatric community-acquired pneumonia.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Volumn 47 Suppl 3, Issue , 2008, Pages

  Bradley, John S ^a   McCracken, George H ^a  

^a RADY CHILDREN'S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ADULT; CHILD; CLINICAL TRIAL; COMMUNICABLE DISEASE; HUMAN; INFANT; PNEUMONIA; PRESCHOOL CHILD; REVIEW; TREATMENT OUTCOME;

ADULT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; CLINICAL TRIALS AS TOPIC; COMMUNITY-ACQUIRED INFECTIONS; HUMANS; INFANT; PNEUMONIA; TREATMENT OUTCOME;

EID: 58149242812     PISSN: None     EISSN: 15376591     Source Type: Journal    
DOI: 10.1086/591410     Document Type: Review

References (52)